Matrix, LAV co-lead $62m round in Chinese biotech firm NovoCodex

Matrix, LAV co-lead $62m round in Chinese biotech firm NovoCodex

Photo: Pixabay

Liya Su

19 March, 2021

Lilly Asia Ventures (LAV)MatrixPartners ChinaNovoCodex Biopharmaceuticals

Bring stories like this into your inbox every day.

Sign up for our newsletter - The Daily Brief
Subscribe to Newsletter

You may also like

Read more from Greater China

Nikkei Logo
DealStreetAsia Logo
About Us
Team
Advertise
Contact
Careers
Blog
Privacy Policy
Terms & Conditions
© Copyright DEALSTREETASIA 2014-2025 All rights reserved.